What is Healthcare Global Enterprises Ltd (HCG) share price today?

Healthcare Global Enterprises Ltd (HCG) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/HCG for the latest live price, technical analysis, and AI-powered insights.

How to analyse HCG stock?

VestAI provides comprehensive HCG stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Healthcare Global Enterprises Ltd in?

Healthcare Global Enterprises Ltd (HCG) is in the Healthcare sector, Hospital industry on the NSE.

Healthcare Global Enterprises Ltd

Name: Healthcare Global Enterprises Ltd (HCG) Financial Metrics
Creator: VestAI

HCG

NSE· Healthcare

₹655.85

-4.25 (-0.64%)

Updated 11:26 am IST

52W Low · ₹516.8552W High · ₹804.65

Mid Range

Market Cap

₹9494.87L Cr

Volume

73.2K

Prev Close

₹660.10

ISIN

INE075I01017

Orion Score

Fundamentals-based quality & risk · not a recommendation

51/100

Watch

Healthcare Global Enterprises Ltd scores 51/100 (Watch) on the Orion Score — moderate business quality (67), moderate growth (67), weak balance-sheet safety (32) and rich valuation (7). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 8.4× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 5/9Altman Z Safe(3.77)Beneish M Clean(-2.78)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

43/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Moderate

D/E 1.23x — manageable leverage

QUALITY

Low Quality

ROCE 7.6% — poor capital efficiency

MOMENTUM

Bullish

RSI 55.4 — strong momentum

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 662.45
ROCE: 7.63%
ROE (1Y): 1.90%
D/E Ratio: 1.23x
OPM: 9.58%
TTM EPS: ₹0.96
Dividend Yield: 0.00%
Qtrly Sales: ₹650.29 Cr
Qtrly Profit: ₹2.17 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹650.29	₹2.17	9.6%	₹0.15
Q3 2026	₹631.18	₹-9.43	7.8%	₹-0.68
Q2 2026	₹645.16	₹16.27	9.4%	₹1.15
Q1 2026	₹611.8	₹4.75	8.2%	₹0.34
Q4 2025	₹583.43	₹7.36	8.2%	₹0.52

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹2,538.43	₹13.76	₹447.66	8.7%
FY 2025	₹2,218.14	₹44.41	₹422.86	7.9%
FY 2024	₹1,889.91	₹48.16	₹342.78	8.3%
FY 2023	₹1,676.05	₹29.35	₹302.75	10.0%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
HCG ★	₹9,495 Cr	662.45	7.63%	1.90%	1.23x	9.58%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹3,543.24	₹2,707.5	₹2,316.02	₹2,219.52
Equity	₹922.44	₹825.78	₹860.52	₹870.29
Total Debt	₹1,837.22	₹1,274.36	₹901.2	₹914.68
Cash	₹235.87	₹272.61	₹174.62	₹197.51
Net Debt	₹766.36	₹400.14	₹224.72	₹210.12
Working Capital	₹-202.62	₹-63.85	₹10.02	₹32.59

Shareholding Pattern

Q1 FY2027

Promoter

66.66%

FII

8.79%

DII

7.19%

Public

17.36%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	66.66% ↑	8.79% ↑	7.19% ↓	17.36% ↑
Q4 FY2026	64.21% ↑	2.71% ↓	18.89% ↑	14.18% ↓
Q3 FY2026	63.77%	3.22% ↓	18.3% ↓	14.71% ↑
Q2 FY2026	63.78% ↑	3.59% ↑	18.36% ↑	14.28% ↓
Q1 FY2026	62.46% ↓	2.16% ↓	13.22% ↑	22.17% ↑
Q4 FY2025	71.22%	2.44% ↓	12.48% ↓	13.86% ↑
Q3 FY2025	71.22% ↓	2.77% ↓	12.94% ↑	13.07% ↑
Q2 FY2025	71.23%	4.3%	11.64%	12.84%

Corporate Actions

Ex-Date	Action	Details
2026-03-02	RIGHTS	Rights 1:17 @ Premium Rs 502/-

Funds Holding This Stock

33 mutual fund schemes

Tata India Pharma & Healthcare Fund Direct GrowthTATA

5.87%

₹81 Cr

Motilal Oswal Consumption Fund Direct GrowthMOTILAL_OSWAL

5.47%

₹57 Cr

Motilal Oswal Business Cycle Fund Direct GrowthMOTILAL_OSWAL

4.13%

₹62 Cr

Tata Focused Fund Direct GrowthTATA

3.64%

₹64 Cr

Motilal Oswal Multi Cap Fund Direct GrowthMOTILAL_OSWAL

2.95%

₹121 Cr

Bandhan Healthcare Fund Direct GrowthIDFC

2.05%

₹6 Cr

Helios Small Cap Fund Direct GrowthHelios

1.69%

₹18 Cr

Nippon India ELSS Tax Saver Fund Direct GrowthRELIANCE

1.61%

₹237 Cr

Motilal Oswal Services Fund Direct GrowthMOTILAL_OSWAL

1.49%

₹2 Cr

Tata Aggressive Hybrid Fund Direct GrowthTATA

1.31%

₹48 Cr

Analyse HCG with Orion AI

Ask: "Is Healthcare Global Enterprises Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Healthcare Global Enterprises Ltd (HCG) Stock

Healthcare Global Enterprises Ltd is listed on the NSE under the Healthcare sector, Hospital industry. ISIN: INE075I01017. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.